Role of free radicals in sepsis: Antioxidant therapy

被引:155
作者
Victor, VM
Rocha, M
Esplugues, JV
De la Fuente, M
机构
[1] Univ Valencia, Fdn Ctr Nacl Invest Cardiovasc Carlos III, CNIC UVEG, Dept Farmacol,Fac Med, Valencia 46010, Spain
[2] Univ Complutense Madrid, Fac Ciencias Biol, Dept Fisiol Anim, E-28040 Madrid, Spain
关键词
endotoxin; reactive oxygen species; nitric oxide; antioxidant; septic shock; cardiovascular dysfunction; mitochondria; NF-kappa B;
D O I
10.2174/1381612054864894
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Severe sepsis leading to shock is the principal cause of death in intensive care units. It is a systemic inflammatory response caused by excessive secretion of pro-inflammatory mediators, such as tumor necrosis factor-alpha(TNF alpha) and reactive oxygen species (ROS), mainly induced by endotoxin (a major component of the Gram-negative bacterial outer membrane). Immune cells use ROS in order to support their functions and need adequate levels of antioxidant defenses to avoid harmful effects of an excessive ROS production. In addition, nitric oxide (NO) is thought to play a key role in the pathogenesis of sepsis and in the development of multiple organ failure. This article discusses the toxic effects of endotoxin, paying particular attention to cardiovascular damage. It continues by analysing the mechanism by which endotoxin is recognized by specific cells of the immune system, and the pathway leading to nuclear factor-kappa B (NF-kappa B) activation and pro-inflammatory gene transcription. In relation to this process, this review focuses on the involvement of reactive oxygen and nitrogen species. Finally, the protective role of antioxidants against homeostatic disturbances such as those caused by endotoxin toxicity, their potential clinical use and the effects on the redox state of the immune cells is discussed.
引用
收藏
页码:3141 / 3158
页数:18
相关论文
共 204 条
[91]   NITRIC-OXIDE SYNTHASE INHIBITION REVERSES ARTERIOLAR HYPORESPONSIVENESS TO CATECHOLAMINES IN SEPTIC RATS [J].
HOLLENBERG, SM ;
CUNNION, RE ;
ZIMMERBERG, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02) :H660-H663
[92]  
Hotchkiss RS, 1999, J IMMUNOL, V162, P4148
[93]   Inhibitory effect of DCDC on lipopolysaccharide-induced nitric oxide synthesis in RAW 264.7 cells [J].
Huang, YC ;
Guh, JH ;
Cheng, ZJ ;
Chang, YL ;
Hwang, TL ;
Lin, CN ;
Teng, CM .
LIFE SCIENCES, 2001, 68 (21) :2435-2447
[94]   Human Nod1 confers responsiveness to bacterial lipopolysaccharides [J].
Inohara, N ;
Ogura, Y ;
Chen, FF ;
Muto, A ;
Nuñez, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (04) :2551-2554
[95]   Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection [J].
Jack, RS ;
Fan, XL ;
Bernheiden, M ;
Rune, G ;
Ehlers, M ;
Weber, A ;
Kirsch, G ;
Mentel, R ;
Furll, B ;
Freudenberg, M ;
Schmitz, G ;
Stelter, F ;
Schutt, C .
NATURE, 1997, 389 (6652) :742-745
[96]  
JARIWALLA RJ, ASCORBIC ACID BIOCH, P215
[97]   REVERSAL OF ENDOTOXIN-MEDIATED SHOCK BY NG-METHYL-L-ARGININE, AN INHIBITOR OF NITRIC-OXIDE SYNTHESIS [J].
KILBOURN, RG ;
JUBRAN, A ;
GROSS, SS ;
GRIFFITH, OW ;
LEVI, R ;
ADAMS, J ;
LODATO, RF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (03) :1132-1138
[98]   Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery [J].
Kitts, DD ;
Weiler, K .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (16) :1309-1323
[99]   NITRIC-OXIDE SYNTHASES IN MAMMALS [J].
KNOWLES, RG ;
MONCADA, S .
BIOCHEMICAL JOURNAL, 1994, 298 :249-258
[100]   Inhibition of NF-κB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN) [J].
Kotake, Y ;
Sang, H ;
Miyajima, T ;
Wallis, GL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1998, 1448 (01) :77-84